Suzanne Arends

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. doi request reprint Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis
    Suzanne Arends
    Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Ann Rheum Dis 71:966-73. 2012
  2. doi request reprint Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis
    Suzanne Arends
    Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, The Netherlands
    J Rheumatol 38:1644-50. 2011
  3. pmc Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
    Suzanne Arends
    Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, P O Box 30 001, 9700 RB Groningen, The Netherlands
    Arthritis Res Ther 13:R94. 2011
  4. pmc The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study
    Suzanne Arends
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, P, O, Box 30, 001, 9700 RB Groningen, The Netherlands
    Arthritis Res Ther 14:R98. 2012
  5. ncbi request reprint Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice
    Suzanne Arends
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen and Rheumatology, Medical Center Leeuwarden, The Netherlands
    Clin Exp Rheumatol 33:174-80. 2015
  6. doi request reprint Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitis
    Suzanne Arends
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    Curr Opin Rheumatol 24:290-8. 2012
  7. doi request reprint Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica
    Kornelis S M van der Geest
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands
    Rheumatology (Oxford) 54:1397-402. 2015
  8. pmc Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study
    Fiona Maas
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    PLoS ONE 10:e0122693. 2015
  9. pmc Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis
    Suzanne Arends
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Rheumatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands
    PLoS ONE 9:e99685. 2014
  10. pmc Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire
    Freke Wink
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    PLoS ONE 8:e55912. 2013

Collaborators

  • Wayel H Abdulahad
  • Abraham Rutgers
  • Joanne N G Oude Elberink
  • Freke Wink
  • Cees Gm Kallenberg
  • Cecile Grootscholten
  • Anne Marie Buisman
  • Stefan P Berger
  • Marc Bijl
  • Kornelis S M van der Geest
  • Eveline van der Veer
  • Elisabeth Brouwer
  • Annemieke M H Boots
  • Gerda Horst
  • Byrthe J P R Vos
  • Fiona Maas
  • Jolien F van Nimwegen
  • Hendrika Bootsma
  • Johan Bijzet
  • Jan G R de Monchy
  • Jasper J van Doormaal
  • Michel S Brink
  • Sicco van der Heide
  • Peter M A van Ooijen
  • Bart Jan Kroesen
  • Frans G M Kroese
  • Nic J G M Veeger
  • Greetje S van Zuiden
  • Johanna C Kluin-Nelemans
  • Monique Efde
  • Anneke Spoorenberg
  • Pedro G Lorencetti
  • Reinhard Bos
  • Rizwana N Chaudhry
  • Arjan Vissink
  • Andre B Mulder
  • Pieter C van Voorst Vader
  • Marieke van der Heiden
  • Mirjam P Roffel
  • Rinze Wolf
  • Joris B Versluijs
  • Sjoukje van der Hoek
  • Wendy J Post
  • Johannes Zwerver
  • Koen Apm Lemmink
  • Chris Visscher

Detail Information

Publications16

  1. doi request reprint Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis
    Suzanne Arends
    Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Ann Rheum Dis 71:966-73. 2012
    ....
  2. doi request reprint Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis
    Suzanne Arends
    Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, The Netherlands
    J Rheumatol 38:1644-50. 2011
    ..To investigate whether level of serum matrix metalloproteinase-3 (MMP-3) can serve as a biomarker for monitoring and predicting response to etanercept treatment in patients with ankylosing spondylitis (AS) in daily clinical practice...
  3. pmc Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
    Suzanne Arends
    Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, P O Box 30 001, 9700 RB Groningen, The Netherlands
    Arthritis Res Ther 13:R94. 2011
    ..The aim of the present study was to identify baseline predictors of response and discontinuation of TNF-α blocking therapy in AS patients in daily clinical practice...
  4. pmc The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study
    Suzanne Arends
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, P, O, Box 30, 001, 9700 RB Groningen, The Netherlands
    Arthritis Res Ther 14:R98. 2012
    ....
  5. ncbi request reprint Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice
    Suzanne Arends
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen and Rheumatology, Medical Center Leeuwarden, The Netherlands
    Clin Exp Rheumatol 33:174-80. 2015
    ..In view of potential side effects and high costs of long-term treatment, our aim was to investigate whether dose reduction of TNF-α blocking agents is possible without loss of effectiveness in AS patients in daily clinical practice...
  6. doi request reprint Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitis
    Suzanne Arends
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    Curr Opin Rheumatol 24:290-8. 2012
    ....
  7. doi request reprint Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica
    Kornelis S M van der Geest
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands
    Rheumatology (Oxford) 54:1397-402. 2015
    ..To compare multiple serum markers for their ability to detect active disease in patients with GCA and in those with PMR...
  8. pmc Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study
    Fiona Maas
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    PLoS ONE 10:e0122693. 2015
    ....
  9. pmc Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis
    Suzanne Arends
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Rheumatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands
    PLoS ONE 9:e99685. 2014
    ..Our aim was to investigate the association of bone turnover markers (BTM) with spinal radiographic damage and bone mineral density (BMD) in AS patients with active disease...
  10. pmc Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire
    Freke Wink
    Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    PLoS ONE 8:e55912. 2013
    ..The aim of this study was to translate the measure into Dutch and to determine its psychometric properties...
  11. doi request reprint Monitoring stress and recovery: new insights for the prevention of injuries and illnesses in elite youth soccer players
    Michel S Brink
    Center for Human Movement Sciences, University Medical Center Groningen, University of Groningen, PO Box 196, 9700 AD Groningen, The Netherlands
    Br J Sports Med 44:809-15. 2010
    ..The aim of this study is to investigate how measures to monitor stress and recovery, and its analysis, provide useful information for the prevention of injuries and illnesses in elite youth soccer players...
  12. doi request reprint Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects
    Byrthe J P R Vos
    Department of Allergology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    J Allergy Clin Immunol 135:792-8. 2015
    ..The influence of these factors on urinary methylhistamine (MH) and methylimidazole acetic acid (MIMA) is still unknown...
  13. doi request reprint Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis
    Suzanne Arends
    aRheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen bRheumatology, Medical Center Leeuwarden cLaboratory Medicine, University of Groningen, University Medical Center Groningen, The Netherlands
    Curr Opin Rheumatol 26:259-68. 2014
    ..To provide an overview of clinical trials and observational studies investigating the effect of tumor necrosis factor-alpha (TNF-α) blocking therapy on bone formation and bone loss in patients with ankylosing spondylitis (AS)...
  14. pmc Quantifying Distribution of Flow Cytometric TCR-Vβ Usage with Economic Statistics
    Kornelis S M van der Geest
    Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    PLoS ONE 10:e0125373. 2015
    ..Application of the Gini-TCR skewing index to the flow cytometric TCR-Vβ analysis will greatly help to gain better understanding of the TCR repertoire in health and disease. ..
  15. doi request reprint The impact of primary Sjögren's syndrome on female sexual function
    Jolien F van Nimwegen
    Department of Rheumatology and Clinical Immunology and Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Rheumatology (Oxford) 54:1286-93. 2015
    ..Our aim was to compare sexual function and sexual distress in women with pSS with healthy controls, as well as to assess parameters that are associated with sexual dysfunction and distress in pSS...
  16. doi request reprint Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis
    Eveline van der Veer
    Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Electronic address
    J Allergy Clin Immunol 134:1413-21. 2014
    ..Fragility fractures (FFxs) and osteoporosis occur frequently in patients with indolent systemic mastocytosis (ISM), even before 50 years of age...